139 related articles for article (PubMed ID: 2680506)
1. Antiarrhythmic efficacy and tolerance of oral propafenone in patients with frequent ventricular arrhythmias: experience of a multicentre study.
Geibel A; Meinertz T; Zehender M; Vitak J; Hohnloser S; Kunz-Fritze A; Just H
Eur Heart J; 1989 Sep; 10 Suppl E():81-7. PubMed ID: 2680506
[TBL] [Abstract][Full Text] [Related]
2. [Diprafenone--comparative study of anti-arrhythmia therapy with propafenone].
Geibel A; Zehender M; Hohnloser S; Landsrath C; Meinertz T; Just H
Z Kardiol; 1988 Jul; 77(7):464-9. PubMed ID: 2463720
[TBL] [Abstract][Full Text] [Related]
3. Short-term and long-term treatment with propafenone: determinants of arrhythmia suppression, persistence of efficacy, arrhythmogenesis, and side effects in patients with symptoms.
Zehender M; Hohnloser S; Geibel A; Furtwängler A; Olschewski M; Meinertz T; Just H
Br Heart J; 1992 Jun; 67(6):491-7. PubMed ID: 1622701
[TBL] [Abstract][Full Text] [Related]
4. Sustained therapeutic efficacy and safety of oral propafenone for treatment of chronic ventricular arrhythmias: a 2-year experience.
Dinh H; Baker BJ; de Soyza N; Murphy ML
Am Heart J; 1988 Jan; 115(1 Pt 1):92-6. PubMed ID: 3336989
[TBL] [Abstract][Full Text] [Related]
5. Effects of propafenone on ventricular arrhythmias: double-blind, parallel, randomized, placebo-controlled dose-ranging study.
Singh BN; Kaplinsky E; Kirsten E; Guerrero J
Am Heart J; 1988 Dec; 116(6 Pt 1):1542-51. PubMed ID: 3057844
[TBL] [Abstract][Full Text] [Related]
6. [Amiodarone and propafenone: evaluation using serial Holter recordings in patients with ventricular arrhythmia].
Ventosa A; Adragão P; Bonhorst D; Seabra-Gomes R
Rev Port Cardiol; 1990 Jan; 9(1):33-9. PubMed ID: 1691653
[TBL] [Abstract][Full Text] [Related]
7. [Propafenone and flecainide in the therapy of ventricular arrhythmias].
Paperini L; Davini A; Lattanzi F; Topi A; Reisenhofer B; Squarcini G; Paci A; Topi PL
Minerva Cardioangiol; 1995 Oct; 43(10):449-57. PubMed ID: 8819814
[TBL] [Abstract][Full Text] [Related]
8. Propafenone. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in the treatment of arrhythmias.
Harron DW; Brogden RN
Drugs; 1987 Dec; 34(6):617-47. PubMed ID: 3322781
[TBL] [Abstract][Full Text] [Related]
9. [Evaluation of the rate for reaching steady state during oral propafenone therapy in patients with ventricular arrhythmias].
Dabrowski R; Skrabucha B; Kunicki PK; Kowalik I; Skorykow-Sapińska A; Sitkiewicz D; Sadowski Z
Pol Arch Med Wewn; 1998 Apr; 99(4):323-30. PubMed ID: 9760820
[TBL] [Abstract][Full Text] [Related]
10. [Cibenzoline versus propafenone by the oral route for preventing recurrence of atrial arrhythmia: multicenter, randomized, double-blind study].
Lardoux H; Maison Blanche P; Marchand X; Canler A; Rouesnel P; Bleinc D; Péraudeau P; Scheck F
Ann Cardiol Angeiol (Paris); 1996 Oct; 45(8):469-79. PubMed ID: 8952741
[TBL] [Abstract][Full Text] [Related]
11. Oral propafenone therapy for children with arrhythmias: efficacy and adverse effects in midterm follow-up.
Guccione P; Drago F; Di Donato RM; Cicini MP; Pasquini L; Marino B; Marcelletti C; Ragonese P
Am Heart J; 1991 Oct; 122(4 Pt 1):1022-7. PubMed ID: 1927853
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of propafenone compared with quinidine in chronic ventricular arrhythmias.
Dinh HA; Murphy ML; Baker BJ; deSoyza N; Franciosa JA
Am J Cardiol; 1985 Jun; 55(13 Pt 1):1520-4. PubMed ID: 3890510
[TBL] [Abstract][Full Text] [Related]
13. Propafenone versus disopyramide: a double-blind randomized crossover trial in patients presenting chronic ventricular arrhythmias.
Libersa C; Caron J; Pladys A; Beuscart R; Kacet S; Wajman A; Connell C; Dupuis B; Lekieffre J
Clin Cardiol; 1987 Jul; 10(7):405-10. PubMed ID: 2440632
[TBL] [Abstract][Full Text] [Related]
14. [Propafenone: evaluation of antiarrhythmic efficacy in hyperkinetic ventricular arrhythmia using acute oral test].
Boriani G; Capucci A; Balducelli M; Frabetti L; Marchesini B; Tomasi L; Ambrosioni E; Magnani B
Cardiologia; 1988 Nov; 33(11):1061-7. PubMed ID: 2475253
[No Abstract] [Full Text] [Related]
15. [Evaluation of the anti-arrhythmic action of propafenone treatment and its influence on left ventricular function].
Saitta A; Bonaiuto M; Mileto A; Oriti S; Cinquegrani M; Giordano G; Fodale P; Saitta M; Squadrito F
Clin Ter; 1993 Apr; 142(4):351-60. PubMed ID: 8330479
[TBL] [Abstract][Full Text] [Related]
16. Short- and long-term effects of propafenone in ventricular arrhythmias.
Gaita F; Richiardi E; Bocchiardo M; Asteggiano R; Pinnavaia A; Di Leo M; Rosettani E; Brusca A
Int J Cardiol; 1986 Nov; 13(2):163-70. PubMed ID: 3793276
[TBL] [Abstract][Full Text] [Related]
17. [Comparative studies of tocainide and propafenone in the treatment of ventricular arrhythmias].
Gebhardt A; Schmuderer R; Hilpert P
Arzneimittelforschung; 1984; 34(3):303-6. PubMed ID: 6428425
[TBL] [Abstract][Full Text] [Related]
18. [Efficacy of propafenone in the treatment of ventricular hyperkinetic arrhythmias in subjects with a history of myocardial infarction].
Zoni Berisso M; Carratino L; De Caro E; Ferroni A; Vecchio C
G Ital Cardiol; 1987 Mar; 17(3):233-8. PubMed ID: 3301504
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of oral propafenone in chronic ventricular arrhythmias: a placebo controlled cross-over exercise study.
Härtel G
Eur Heart J; 1985 Feb; 6(2):123-9. PubMed ID: 3891347
[TBL] [Abstract][Full Text] [Related]
20. Safety of oral propafenone in the treatment of arrhythmias in infants and children (European retrospective multicenter study). Working Group on Pediatric Arrhythmias and Electrophysiology of the Association of European Pediatric Cardiologists.
Janousek J; Paul T
Am J Cardiol; 1998 May; 81(9):1121-4. PubMed ID: 9605053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
